Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease

• Status: Terminated
• Trial end date: 2010-08-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to assess the safety and efficacy of Dimebon in combination with donepezil (Aricept) in the treatment of Alzheimer's disease.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Medivation, Inc.
• Treatments: Donepezil

Criteria

Inclusion Criteria:

• Alzheimer's disease

• On donepezil (Aricept)

• Caregiver who cares for the patient at least 5 days per week

Exclusion Criteria:

• Unstable medical illnesses or significant hepatic or renal disease

• Other primary psychiatric or neurological disorders